Authors
Memoona Rajput, Lydie Flasse, Esther Porée, Océane Pointeau, Alice Serafin, Nicolas Papadopoulos, Younes Achouri, Joel Moro, Axelle Loriot, Michaela Wilsch-Brauninger, Valentine Gillion, Nathalie Godefroid, Charlotte Bodson, Leyre Lopez Muneta, Constance Depestel, Marie Morel, Sabine Cordi, Antonio Garcia de Herreros, Cecile Haumaitre, Frédéric Lemaigre, Meritxell Rovira, Amandine Viau, Anne Grapin-Botton, Sophie Saunier, Patrick Jacquemin, Isabelle Scheers
Published in
Gut. Aug 18, 2026. Epub Aug 18, 2026.
Abstract
While pancreatic cysts have been described in syndromic ciliopathies, the pancreas is not commonly recognised as a target organ. However, several ciliary gene knockout mouse models develop a pancreatic phenotype combining acinar atrophy and adipocyte accumulation, here called adipopancreatosis, suggesting a link between ciliary dysfunction and pancreatic disease.
We investigated whether mutations in ciliopathy-associated genes are linked to pancreatic dysfunction in humans.
We analysed a cohort of 341 patients with paediatric-onset pancreatic anomalies and characterised the pancreatic phenotype of new mouse models with conditional Nphp3 inactivation or bearing Nphp3 mutations recapitulating human mutations. In patients, pancreatic fat content was quantified using Dixon-MRI.
Mutations in the cilium-related HNF1B and NPHP3 were identified in patients presenting with both renal and pancreatic dysfunction. Nphp3 mutant mice developed acinar atrophy, adipopancreatosis and moderate inflammation. Adipocytes in the pancreas exhibited a white adipocyte-like profile and may originate from mesothelial-derived fibroblasts. Reduced numbers and altered length of ductal cilia were monitored. Interestingly, secretory canaliculi, typically unnoticed structures found within and between acinar cells and connected to the acinar lumen, exhibited a microcystic morphology. Consistent with the mouse phenotype, Dixon-MRI revealed significantly increased pancreatic fat content in patients with HNF1B and NPHP3 mutations.
We describe a previously unrecognised pancreatic manifestation of ciliopathies, which we name ciliogenic pancreatopathy. Patients with known ciliopathy-causing mutations should be evaluated for this pancreatic condition, particularly those with kidney disease, as concomitant exocrine pancreatic insufficiency may further compromise renal function or the outcome of kidney graft.
PMID:
42613169
Bibliographic data and abstract were imported from PubMed on 19 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0